-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mmmo+oT+tDwKj0pzSwqA+9WZgpAGcfb5Hz7GhhvZ94IU1z7dlGngbZTNX0HS2hqw j9C951U79KUTqqh3Zd3EMA== 0001140361-07-008160.txt : 20070423 0001140361-07-008160.hdr.sgml : 20070423 20070423123715 ACCESSION NUMBER: 0001140361-07-008160 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070420 FILED AS OF DATE: 20070423 DATE AS OF CHANGE: 20070423 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwanicki David CENTRAL INDEX KEY: 0001322481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 07780993 BUSINESS ADDRESS: BUSINESS PHONE: 510-574-1400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc1.xml FORM 4 X0202 4 2007-04-20 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001322481 Iwanicki David C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 VP, Sales & Sales Operations Common Stock 2007-04-20 4 M 0 645 17.13 A 645 D Common Stock 2007-04-20 4 S 0 64 23.87 D 581 D Common Stock 2007-04-20 4 S 0 64 23.88 D 517 D Common Stock 2007-04-20 4 S 0 133 23.98 D 384 D Common Stock 2007-04-20 4 S 0 64 23.76 D 320 D Common Stock 2007-04-20 4 S 0 64 23.82 D 256 D Common Stock 2007-04-20 4 S 0 64 23.87 D 192 D Common Stock 2007-04-20 4 S 0 64 23.94 D 128 D Common Stock 2007-04-20 4 S 0 64 23.95 D 64 D Common Stock 2007-04-20 4 S 0 64 24.16 D 0 D Employee Stock Option (Right to Buy) 17.13 2007-04-20 4 M 0 645 0 D 2013-07-20 Common Stock 645 25195 D Sale was made pursuant to a 10b5-1 plan established by the reporting person. Option vests with respect to approximately 645 shares per month and 7 shares remained exercisable immediately after this transaction. Only vested options are exercisable /s/ Francis Sarena by Francis Sarena, Attorney in Fact for David Iwanicki 2007-04-23 -----END PRIVACY-ENHANCED MESSAGE-----